$17.63
In chiusura: Oct 14 EDT
$17.63
0.000.00%
Pre-mercato: 4:43 PM EDT
Sabra Health Care REIT fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
08/04/2025 | SBRA | Sabra Health Care REIT | FY | 2025 | $1.45 | $1.47 | $1.00 | — | — | — | |
05/05/2025 | SBRA | Sabra Health Care REIT | FY | 2025 | $1.43 | $1.46 | $1.46 | — | — | — | |
02/19/2025 | SBRA | Sabra Health Care REIT | FY | 2025 | $1.43 | $1.46 | $1.48 | — | — | — | |
10/31/2024 | SBRA | Sabra Health Care REIT | FY | 2024 | $1.39 | $1.40 | $1.38 | — | — | — | |
08/07/2024 | SBRA | Sabra Health Care REIT | FY | 2024 | $1.36 | $1.39 | $1.38 | — | — | — | |
05/08/2024 | SBRA | Sabra Health Care REIT | FY | 2024 | $1.34 | $1.38 | $1.37 | — | — | — | |
02/27/2024 | SBRA | Sabra Health Care REIT | FY | 2024 | $1.39 | $1.43 | $1.38 | — | — | — | |
11/03/2021 | SBRA | Sabra Health Care REIT | FY | 2021 | $1.51 | $1.53 | — | — | — | — | |
09/13/2021 | SBRA | Sabra Health Care REIT | FY | 2021 | $1.51 | $1.53 | — | — | — | — | |
08/04/2021 | SBRA | Sabra Health Care REIT | FY | 2021 | $1.51 | $1.53 | — | — | — | — | |
06/08/2021 | SBRA | Sabra Health Care REIT | Q2 | 2021 | $0.37 | $0.38 | — | — | — | — | |
05/19/2021 | SBRA | Sabra Health Care REIT | Q2 | 2021 | $0.37 | $0.38 | — | — | — | — | |
05/05/2021 | SBRA | Sabra Health Care REIT | Q2 | 2021 | $0.38 | $0.39 | — | — | — | — | |
03/08/2021 | SBRA | Sabra Health Care REIT | Q1 | 2021 | $0.38 | $0.39 | — | — | — | — | |
02/22/2021 | SBRA | Sabra Health Care REIT | Q1 | 2021 | $0.38 | $0.39 | — | — | — | — |
Le ultime previsioni per Sabra Health Care REIT (SBRA) sono state riportate il agosto 4, 2025 per l'intero anno 2025. L'azienda ha fornito una previsione di utili per azione nell'intervallo da $1.45 a $1.47, rispetto all'EPS stimato di $1.00. Inoltre, Sabra Health Care REIT ha previsto ricavi tra $0.00B e $0.00B per il trimestre.
Sfoglia guidance e previsioni su tutte le azioni.